Eli Lilly's direct-to-consumer platform LillyDirect has been expanded to include in-person and telehealth services for people ...

Italy's Chiesi Group has revealed plans to spend €430 million ($464 million) on a new therapeutics manufacturing facility at ...

New US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has said he intends to save $1.8 billion per year, ...

Last year, surgeons in the US carried out the first transplant of a genetically modified pig kidney into a male subject, who ...

Soleno Therapeutics' Vykat XR has become the first FDA-approved treatment for Prader-Willi syndrome (PWS), a rare genetic ...

The company ended 2024 with just under $127 million in cash reserves, and nothing in its pipeline beyond the Alzheimer's ...

The growing burden of misinformation is a complex issue that demands a direct-to-patient channel through trusted sources. By ...

Alcon said that its majority stake means that Aurion will have "broader R&D, regulatory, medical ophthalmic, and commercial ...

Jean-François Toussaint, Sanofi's global head of vaccines R&D, speaking at a conference at the company's site in Lyon last ...

The Government's recently launched AI Action Plan, focusing on creating a National Data Library, marks a pivotal moment for ...

Brian Hilberdink says he wasn’t looking for a new job when he got the call from Boehringer Ingelheim to join up as their new ...

The FDA has approved GSK's gepotidacin, the first oral antibiotic to offer a new mechanism of action in uncomplicated urinary ...